2006 Consulting Diabetes Relationship 
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. “You want someone who can monitor patients’ side effects and have a longitudinal relationship with them.”
Permanente Medicine
JUNE 3, 2025
I joined SCPMG straight from residency in 2006. So it’s not uncommon that many patients start to ask certain questions and I’m like, did you happen to consult with Dr. Google before coming to see me? Let’s say a diabetic comes in and they’re on metformin. Dr. Marcos, tell us who you are and what you do.
Expert insights. Personalized for you.
66 
Let's personalize your content